Kyverna Therapeutics KYTX 深 沪
已收盘 08-01 16:00:00 美东时间
3.44
-0.130
-3.64%
华盛通- 最 高3.56
- 今 开3.52
- 成交量 10.96万股
- 最 低 3.40
- 昨 收 3.57
- 总市值 1.49亿
- 52周最高 8.78
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.78
- 委 比 66.75%
- 总股本 4321.89万
- 历史最高 35.06
- 量 比 0.57
- 振 幅 4.48%
- 历史最低 1.78
- 每 手 1
- 风险率 8.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kyverna Therapeutics appoints Marc Grasso as CFO
Kyverna Therapeutics (NASDAQ:KYTX) announced on Monday the appointment of Marc Grasso as its chief financial officer (CFO), effective today. Most recently, Grasso served as CFO of Alector, a clinical...
06-30 21:32
美股大行评级 | 潜在涨幅1562.13%！Cingulate获Ascendiant Capital升目标价至61美元，维持"买入"评级
潜在涨幅1562.13%！Cingulate获Ascendiant Capital升目标价至61美元，维持"买入"评级
05-28 09:04
HC Wainwright & Co. Upgrades Kyverna Therapeutics to Buy, Raises Price Target to $5
HC Wainwright & Co. analyst Mitchell Kapoor upgrades Kyverna Therapeutics (NASDAQ:KYTX) from Neutral to Buy and raises the price target from $4 to $5.
05-27 18:56
快讯 | Kyverna Therapeutics Inc - 预计将在2026年上半年提交Kyv-101的BLA申请
Kyverna Therapeutics Inc - Anticipates Bla Filing for Kyv-101 in 1H 2026
05-14 04:26
Kyverna Therapeutics Q1 EPS $(1.03) Misses $(0.99) Estimate
Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(0.99) by 4.04 percent. This is a 8.04 percent increase over losses of $(1.12) per share
05-14 04:14
快讯 | Kyverna Therapeutics提供了业务更新并报告了2025年第一季度的财务结果
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Fi...
05-14 04:02
美股大行评级 | 潜在涨幅117.92%！Proficient Auto Logistics获Stifel升目标价至18美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1114836103639961600.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Stifel：维持Proficient Auto Logistics(PAL)"买入"评级，目标价从17美元升至18美元</p> <p>• Craig-Hallum：上调Sportsman's Warehouse(SPWH
04-04 15:42
美股大行评级 | 潜在涨幅4159%！HC Wainwright & Co.上调BiomX目标价至21美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1114111385008877568.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BiomX(PHGE)"买入"评级，目标价从2美元升至21美元</p> <p>• HC Wainwright & Co.：维持Unicycive Therapeu
04-02 09:42
Kyverna Therapeutics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
04-01 20:30
快讯 | Kyverna Therapeutics Inc：摩根士丹利将目标价从40美元下调至20美元
Kyverna Therapeutics Inc : Morgan Stanley Cuts Target Price to $20 From $40
04-01 19:10
